GLUE Monte Rosa Therapeutics, Inc.
$11.26
Monte Rosa Therapeutics, Inc. (GLUE) Earnings News
Earnings press releases, previews and reviews for Monte Rosa Therapeutics, Inc. (GLUE), newest first.
Wednesday
September 30, 2026
4:01 PM ET
Monte Rosa Therapeutics to Present Results of MRT-8102 GFORCE-1 Phase 1 Study in Subjects with Elevated Cardiovascular Disease Risk
Thursday
August 6, 2026
7:00 AM ET
Monte Rosa Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates
Thursday
May 7, 2026
7:00 AM ET
Monte Rosa Therapeutics Announces First Quarter 2026 Financial Results and Business Updates